Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.38 |
| ▸ | ABAT | P80404 | 1/20 | 0.38 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.36 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 4/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27944694 | 0.95 | ALDH1A1 (0.48) | FDPSALDH1A1TSHRMAPK1L3MBTL1 | |
| SCHEMBL30875129 | 0.95 | ALDH1A1 (0.48) | FDPSALDH1A1TSHRMAPK1L3MBTL1 | |
| SCHEMBL2744767 | 0.91 | ALDH1A1 (0.50) | FDPSALDH1A1TSHRMAPK1L3MBTL1 | |
| SCHEMBL31471641 | 0.91 | FDPS (0.46) | FDPSALDH1A1TSHRMAPK1L3MBTL1 | |
| SCHEMBL23202773 | 0.88 | ALDH1A1 (0.56) | FDPSALDH1A1TSHRMAPK1L3MBTL1 | |
| SCHEMBL7680122 | 0.88 | ALDH1A1 (0.44) | FDPSALDH1A1TSHRMAPK1L3MBTL1 | |
| SCHEMBL3123095 | 0.87 | FDPS (0.41) | FDPSALDH1A1TSHRMAPK1L3MBTL1 | |
| SCHEMBL13116218 | 0.84 | SRC (0.42) | FDPSALDH1A1TSHRMAPK1L3MBTL1 | |
| SCHEMBL7951806 | 0.84 | FDPS (0.41) | FDPSALDH1A1TSHRMAPK1L3MBTL1 | |
| SCHEMBL21722590 | 0.83 | ALDH1A1 (0.46) | FDPSALDH1A1TSHRMAPK1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116514759-A | Synthesis method of dihydromyricetin | 华中农业大学 | 2023-08-01 | — | — | CN | claimed |
| CN-116514759-A | Synthesis method of dihydromyricetin | 华中农业大学 | 2023-08-01 | — | — | CN | disclosed |
| US-11643405-B2 | Compound for treatment or prevention of liver diseases | JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO., LTD. (CN) | 2023-05-09 | — | — | US | disclosed |
| US-11643405-B2 | Compound for treatment or prevention of liver diseases | JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO., LTD. (CN) | 2023-05-09 | — | — | US | disclosed |
| CN-110183431-B | Compound for treating or preventing liver diseases | 江苏新元素医药科技有限公司 | 2023-04-11 | — | — | CN | disclosed |
| US-20210246126-A1 | COMPOUND FOR TREATMENT OR PREVENTION OF LIVER DISEASES | JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO., LTD. (CN) | 2021-08-12 | — | — | US | disclosed |
| EP-3805216-A1 | COMPOUNDS FOR TREATMENT OR PREVENTION OF LIVER DISEASES | Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd. (CN) | 2021-04-14 | — | — | EP | disclosed |
| US-20090092624-A1 | Antiinfective Flavononol Compounds and Methods of Use Thereof | HERBALSCIENCE GROUP, LLC | 2009-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210246126-A1 | COMPOUND FOR TREATMENT OR PREVENTION OF LIVER DISEASES | SLC10A1, GYS2, CPT1A | FDPS 203/4885ALDH1A1 164/4885TSHR 2573/4885 |
| US-20090092624-A1 | Antiinfective Flavononol Compounds and Methods of Use Thereof | MPO, VIP, FABP2 | FDPS 147/4885ALDH1A1 894/4885TSHR 4811/4885 |
| US-11643405-B2 | Compound for treatment or prevention of liver diseases | SLC10A1, GYS2, CPT1A | FDPS 203/4885ALDH1A1 164/4885TSHR 2573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.